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ABSTRACT
Objective: The aim of this study was to investigate physical characteristics of nanostructured lipid carriers (NLCs) mixture of alpha tocopheryl 
acetate, cetyl palmitate, Tween 80 and propylene glycol using high shear homogenization technique on NLC preparation to predict the optimum 
ratio of alpha tocopheryl acetate-cetyl palmitate to produce good characteristics of NLC loaded coenzyme, higher % EE, good penetration, controlled 
release, and stable.
Methods: Lipid characterizations were conducted by diffraction scanning calorimetry, X-ray diffraction, and Fourier transforms infrared 
spectrophotometry. Coenzyme Q10 concentration was measured by spectrophotometer at 275 nm. NLC characteristics based on their morphology 
was determined using transmission electron microscope, particle size, and its polydispersity index which were measured with Delsa Nano™ particle 
size analyzer. Percentage of coenzyme Q10 entrapped in NLC was determined by dialysis bag method. Coenzyme Q10 release profile was measured 
using with Franz cell for 12 hrs. The penetration depth of NLC coenzyme Q10 in abdominal skin of Wistar rat was determined with fluorescence 
microscopy using rhodamine B as marker. NLC physical stability based on minimum of particle size variation, pH and viscosity during 90 days storage.
Results: The result showed that formula with ratio of cetyl palmitate-alpha tocopheryl acetate 70:30 (% w/w) produce good characteristics of NLC 
loaded coenzyme, higher % EE, good penetration, controlled release, and stable in 90 days storage.
Conclusion: The coenzyme Q10 NLC  system with cetyl palmitate and alpha tocopherol acetate as lipid matrixare characterized by small particle size, 
low crystallinity, spherical morphology of particle and high coenzyme Q10 entrapment efficiency. Crystal modification led to the formation of a more 
amorphous thereby increasing the drug entrapment
Keywords: Coenzyme Q10, Nanostructured lipid carrier, Cetyl palmitate, Alpha tocopheryl acetate, High shear homogenization.
INTRODUCTION
Coenzyme Q10 (also called ubiquinone, ubidecarenone, coenzyme 
Q10 or Q10) is a lipid soluble compound found naturally in plants 
and animals, as well as in microorganisms. The chemical structure 
of coenzyme Q10 consists of a quinone ring attached to an isoprene 
side chain. The number of isoprene units in the side chain varies with 
each species of plants and animals. Coenzyme Q10 in humans has 10 
isoprene units, therefore, it is known as coenzyme Q10 [1]. Coenzyme 
Q10 plays an important role in the mitochondrial electron transport 
chain as an electron carrier. It exists in two redox forms, an oxidized 
and a reduced form. The reduced form of coenzyme Q10, ubiquinol, is 
the only endogenously synthesized fat-soluble antioxidant protecting 
cellular membranes and plasma lipoproteins from lipid peroxidation [2]. 
Therefore, roles of coenzyme Q10 in the biological system could be 
categorized into two important purposes, one involving in the oxidative 
phosphorylation process to generate ATP and the other being involved 
in preventing lipid oxidation and scavenging superoxide [1,3].
Coenzyme Q10 is known as an endogenous cellular antioxidant. It is 
composed of a long side chain containing 10 isoprenoid units. Due 
to its structure, the aqueous solubility is very low, causing a low oral 
bioavailability [4]. In terms of cosmetic applications, this active has 
shown the ability to reduce photoaging in vivo with a corresponding 
decrease in wrinkle depth [5-7].
Coenzyme Q10 shaped crystalline powder, insoluble in water, has a 
high lipophilicity properties. Coenzyme Q10 solubility in water is very 
low (4 ng/ml), causing low bioavailability and permeability of the oral 
administration [8]. Antioxidant compounds are compounds that are 
not stable in the presence of light and oxidizing substances present in 
the air. One of the main issues of the use of coenzyme Q10 is related to 
the potential efficacy as determined by absorption and bioavailability. 
Coenzyme Q10 has a complex chemical structure that formulations do 
have to get an effective product with good stability [4].
Nanostructured lipid carriers (NLCs) have many advantages such as 
occlusion and skin hydration, absorption-increasing effects, active 
penetration enhancement, and controlled-release properties. NLC 
was developed by exchanging the liquid lipid (oil) of oil-in-water 
(o/w) emulsions by a solid lipid, which can bring many advantages 
in comparison to a liquid core. The concept of NLC was developed by 
nanostructuring the lipid matrix, to give more flexibility for modulation 
of drug release, increasing the drug loading and preventing its leakage. 
The result is a less ordered lipid matrix with many imperfections, which 
can accommodate a higher amount of drug. The other advantages of 
using lipids as carrier systems for skin administration are related to 
their physiological and well-tolerated nature, which reduces the risk 
of toxicological problems and local irritancy [9,10]. NLCs are lipid 
nanoparticles that can increase the penetration of lipophilic drug 
substance, as it has occlusive properties and improves skin hydration. 
Therefore, Coenzyme Q10 encapsulated in the NLC system to increase 
its penetration into the skin [11,12].
MATERIALS AND METHODS
Materials
Coenzyme Q10 was obtained from Xi’an Future Biotechnology, Co., 
Ltd., cetyl palmitate (Cutina® CP) was obtained from Cognis Chemical 
Care, alpha tocopherol acetate was obtained from Xinchang pharma, 
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i2.14835
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propylene glycol was obtained from Dow Chemical Pacific, Tween 80 was 
obtained from KAO corporation, Ethanol p.a, NaOH (sodium hydroxide) 
and NaH2PO4 (natrium dehydrogenate phosphate) p.a were product 
of Merck. Aquabidestilata was gift sample from PT. Widatra Bhakti, 
Pasuruan, Indonesia. All other ingredients used were analytical grade.
Methods
Preparation of coenzyme Q10 NLC system
The method of this research is using high shear homogenization. Coenzyme 
Q10 NLC system was made by melting the lipid phase (cetyl palmitate 
and alpha tocopheryl acetate) with different lipid ratio (70:30, 80:20, 
and 90:10), and Coenzyme Q10 at 65°C temperature. At the same time, 
the surfactant solution (propylene glycol, Tween-80, and pH phosphate 
buffer 6.0±0.05) was prepared and heated at the same temperature. Then, 
this heated surfactant solution is dispersed into heated lipid phase by 
using Ultra-Turax at 24,000 rpm speed for 2 minutes. Subsequently, the 
NLC dispersions were formed simply by cooling the warm pre-emulsion 
precursor to room temperature in the same container [3,13]. The 
composition of coenzyme Q10 NLC system can be seen in Table 1.
Physical and chemical characterization of coenzyme Q10 NLC 
system
Fourier transforms infrared (FTIR) spectroscopy
The sample was combined with KBr and pressed into a pellet (ratio 1:1). 
The solid pellet was analyzed using spectroscopy FTIR Jasco 4200; the 
examination was conducted in wave number range of 4000-400/cm. 
Infrared spectra obtained were compared with literature.
pH
The electrode was inserted into 10 ml coenzyme Q10 NLC; the electrode 
must be sinked into sample. The pH values observed until the screen 
showed a stable number.
Viscosity
Viscosity observed to know the thickness of coenzyme Q10 NLC 
system. It was analyzed with cone and plate viscometer. 2.0 ml amount 
of coenzyme Q10 NLC system placed on the sample cup, then the 
viscometer is turned on. Viscosity measured when the value is showed 
stable.
Particle size and size distribution
Examination of particle size and size distribution has done by 
Delsa™Nano Submicron 2.0 ml amount of sample coenzyme Q10 system 
dilute with 10.0 ml aquadest. Particle size analyzer. The tool will 
measure it over 10 minutes. The observed data are the average droplet 
diameter and polydispersity index (PI). PI illustrates the variation on 
the sample. The small value of PI (<0.3) indicates that the sample is 
monodisperse [9].
Zeta potential
Zeta potential was measured using Malvern Instrument® with cell and 
the appropriate procedure. The instrument can measure on 0.001-40% 
concentration. The sample is dispersed into water until it gets the 
concentration on optimum intensity of the instrument. The suspension 
was sonicated for approximately 2 minutes to break agglomerate, then 
it is measured [10].
Particle morphology
This evaluation used to determine the form of particle contained 
in NLC. Coenzyme Q10 NLC system was dispersed in 1% CMC Na 
gel and spreaded on glass platesm then the sample dried to loss the 
water content in NLC system. The dry NLC system coated with Aurum 
before counted in vacuum condition. Particle morphology examination 
observed at 10.000× magnification [4].
Cristallinity
Different scanning calorimetry (DSC)
Sample weighed at 2-8 mg of coenzyme Q10 and cetyl palmitate. 
Sample inserted into an aluminum pan that is impermeable to air. 
This pan is heated to the temperature 30-300°C at calorimeter 
with the temperature rise 10°C every minutes Melting temperature 
measurement observed with thermogram peak.
X-ray diffraction (XRD)
The sample is inserted to the holder glass and the surface is trimmed by 
plate glass. This sample is placed in X-ray Philips X’Pert diffractometer. 
The measurement condition was: 40 kV voltage; 30 mA; 0.5° Divergent 
and scatter slits; 0.15 mm receiving slit. Then, it observed over a range 
of 2θ angle from 5° to 50°.
Entrapment efficiency of coenzyme Q10
Drug E.E was calculated by determining the amount of drug unentrapped 
(Cf) after removal of NLC system by dialysis bag. Coenzyme Q10 which 
is unentrapped in NLC system would be dispersed in phosphate buffer 
with pH 6.0±0.05 as a supernatant. The obtained sample was filtered 
using Millipore Whatman 0.2 µm filter paper. This evaluation used 
ultraviolet (UV) spectrophotometer. Furthermore, it is calculated using 
this following formula:
EE (%) = (Ct-Cf/Ct) × 100%.
Where Ct is the total amount of drug added in the formulation. 
The concentration of drug was determined by double beam UV-VIS 
Table 1: Composition of coenzyme Q10 NLC system




Tween 80 (%b/b) Propyleneglycol (%b/b)
F1 2.4 70 30 20 11
F2 2.4 80 20 20 11
F3 2.4 90 10 20 11
NLC: Nanostructured lipid carrier
Tables 2: Penetration depth of coenzyme Q10 NLC System in each formula
Formula F1
Location Penetration depth after 2nd hrs Penetration depth after 4th hrs Penetration depth after 6th hrs
Epidermis 1137.85 µm (0.11378 mm) - -
Epidermis–Dermis - 1346.15 µm (0.13615 mm) 1367.95 µm (0.136795 mm)
Formula F2
Location Penetration depth after 2nd hrs Penetration depth after 4th hrs Penetration depth after 6th hrs
Epidermis 820.54 µm (0.082054 mm) 867.61 µm (0.086761 mm) 881.27 µm (0.088127 mm)
Formula F3
Location Penetration depth after 2nd hrs Penetration depth after 4th hrs Penetration depth after 6th hrs
Epidermis 589.85 µm (0.058985 mm) 589.85 µm (0.058985 mm) 589.85 µm (0.058985 mm)
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spectrophotometer (Shimadzu UV-1800) with multiple wavelenght 
method [14].
In vivo penetration study of cenzyme Q10 NLC system
Preparation of membrane test
Wistar rat prepared in accordance with the inclusion criteria. Anesthetic 
solution prepared in mice, then anesthetized about 5 minutes, the mice 
will collapse (±45 minutes). Mice placed on a table and four legs dipijat 
with plaster. f. Hair shaved rat abdominal section, it was confirmed that 
the skin after the rats were shaved uninjured. Rat skin area divided by 
hepafix. Weighed 200 mg of the test sample, then gets applied to the 
abdomens of mice, the breadth of 2×3 cm2. After 2 and 4 and 6 hrs, 
mice were killed by cervical dislocation. The skin of the applied sample 
is cut with an area of 1×4 cm2. Thickness of 200 µm using the tool 
dermatomization. After that, the skin tissue was washed three times 
with absolute alcohol. Embedding using samples grown in liquid paraffin 
on beam inert paper. Objects placed in accordance with the orientation 
of the cutting, left to freeze and then stored in the block holder. Samples 
are cut transversely and horizontally using cryotome (Tissue-Tek Cryo3, 
Sakura) at a temperature of −59°C with a size of 1 mm2 and a thickness 
of 5 lm/l. Sliced visualized to determine the depth of penetration by 
using Rhodamine B using a red filter with a fluorescent microscope [8].
Observations with fluorescence microscope
Abdominal skin membrane of male Wistar Rat was examined by 
fluorescence microscope (FSX 100, Olympus). Visualization is done to 
observe the distribution of the stocks that have been given a marker 
Rhodamine B in the skin layer. Images recorded with the integrity of 
camera time is set to 10 m. The sample rate is 4.0 μ detik/pixel. The 
objective lens in the magnification of 20× (7).
Statistical analysis
Characterization evaluation (pH, viscosity, particle size, zeta potential, 
and entrapment efficiency of drug) of Coenzyme Q10 NLC system has 
statistically analyzed using one-way analysis of variance (ANOVA) 
method at 95% level. Then, significantly difference of NLC system 
formula obtained by post-hoc Bonferroni test.
RESULTS AND DISCUSSION
Physical and chemical characterization of meloxicam NLC system
FTIR spectroscopy
The analysis of functional group change in coenzyme Q10 NLC system 
was done by comparing the infrared spectrum of coenzyme Q10 NLC 
system with the material infrared spectrum, which can be seen in 
Figs. 1 and 2.
Coenzyme Q10 NLC system with some ratios of the lipid matrix 
concentration has a similar FTIR spectrum profile. This condition 
shows that there is no difference in the interaction of some components 
when forming the NLC system. This condition shows that there was a 
possibility of intermolecular hydrogen bonds with average strength 
with a hydroxyl group of some component. In addition, there is no new 
characteristic peak that appears in the FTIR spectrum of coenzyme Q10 
NLC system. Based on FTIR spectrum result, it could be seen that there 
was no chemical interaction between Coenzyme Q10 with a constituent 
component of NLC system. There was only physical reaction in NLC 
system formation. The formation of Coenzyme Q10 NLC system with 
lipid matrix of cetyl palmitate and alpha tocopherol acetate can be 
identified from characteristic peak in finger print area.
pH parameter
The pH parameter of coenzyme Q10 NLC system has a connection with 
the pH stability of active ingredient and the convenience in topical 
administration. Topical dosage forms pH applied on the skin should has 
a value on 4.5-6.5.
The obtained NLC system had a pH value in the range of 6.26-6.38. The 
histogram of average pH in some formulas of NLC system can be seen 
in Fig. 3.
Statistically analysis using ANOVA showed that there was no significant 
difference between pH in each formula of NLC system (*p>0.05). Based 
on this results, could be concluded that the ratios of solid and liquid 
lipid matrix did not affect the pH value of NLC system.
Fig. 1: Oxidized and reduced forms of coenzyme Q: In humans, the number of isoprene units (n) is 10
Fig. 2: Fourier transforms infrared spectrum of (a) coenzyme Q10; (b) Cetyl palmitate; (c) alpha tocopherol acetate; (d) Tween 80; 
(e) propyleneglycol; (f) F1; (g) F2; (h) F3
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Viscosity test
Coenzyme Q10 NLC system which has been produced had viscosity 
values from 37.83 to 88.38 c.Ps. The histogram of average viscosity in 
some formulas of NLC system can be seen in Fig. 4.
Statistically analysis using ANOVA showed that there was significantly 
differences (*p<0.05) in ech formula. From post-hoc test result 
(Bonferroni), it could be known that F1 is significantly different from 
F2 and F3 From this result, it can be proved that the increased number 
of liquid lipid which is added to the formula is capable to decrease the 
viscosity values of NLC system.
Viscosity is a barrier of liquid to flow, if the viscosity of the sample is 
higher, the barrier to flow is also high. The viscosity of NLC system is 
affected by the composition of NLC system formula.
Particle size and size distribution of NLC
From the particle examination result of all NLC system formulas, the 
particle size was about <1000 nm. The particle size of Coenzyme 
Q10 NLC system was about 145.27 to 178.3 nm. In addition, the 
histogram of average particle size in some NLC formulas can be seen 
in Fig. 5.
Statistically analysis using ANOVA showed that there was significant 
differences (*p<0.05) in ech formula. From post-hoc test result 
(Bonferroni), it could be known that F1 is significantly different from 
F2 and F3. The particle size of NLC prepared using cetyl palmitate (solid 
lipid) depended on liquid lipid content. A trend toward the decrease in 
particle size with the increase in content was observed. Cetyl palmitate 
is a wax lipid group, has a highly ordered crystal lattice and alpha 
tocopheryl acetate having less ordered crystal lattice. Differences in 
chemistry, physics and crystallographic characteristics of the system 
will affect the NLC.
Statistically analysis of PI using ANOVA showed that there was 
significant differences (*p<0.05) in ech formula. From post-hoc test 
result (Bonferroni), it could be known that F1 is significantly different 
from F2 and F3. The phenomenon of polymorph rapid change affects 
the instability of NLC system, such as the transformation of structure 
particle, agglomeration, and sedimentation in aqueous phase. This 
condition can affect the formation of NLC system with polydisperse 
particle size distribution and higher tendency to agglomeration.
Zeta potential
Zeta potential measurement is an indirect measurement of NLC physical 
stability and it also affects the release kinetics and biological process of 
nanoparticle. Zeta potential is the electrical potential on sliding area, 
which is defined as the electrical charge of outer particle surface where 
the opposite charge still able to strongly bound with other particles 
when they move in an electrical field.
Zeta potential measurement obtained 10.4-15.4 as a negative value. The 
histogram of average zeta potential in all NLC system is shown in Fig. 6.
Statistically analysis of PI using ANOVA showed that there was 
significant differences (*p<0.05) in ech formula. From post-hoc test 
result (Bonferroni), it could be known that F1 is significantly different 
from F2 and F3.
The examination of crystallinity
The XRD data
XRD analysis is used to know the crystallinity change of active substance 
and lipid component in NLC system. XRD’s pattern of coenzyme Q10, 
cetyl palmitate, and some NLC formulas can be seen in Fig. 7.
Fig. 3: The histogram of average pH in some formulas of 
nanostructured lipid carrier system
Fig. 4: The histogram of average viscosity in some formulas of 
nanostructured lipid carrier system
Fig. 5: The histogram of average particle size in some 
nanostructured lipid carrier formulas in aqueous media by 
using DelsaNano®
Fig. 6: The histogram of some nanostructured lipid carrier 
formulas average zeta potential in aqueous media using Malvern 
Instrument®
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At the results of all formulas with different ratio of solid lipid and liquid 
lipid, it was known that NLC system peak intensity has decreased. The 
result showed that NLC system was amorphous form. The condition 
indicated that coenzyme Q10 was entrapped in NLC system.
DSC
DSC analysis provides the data such as thermogram to determine the 
melting point of a sample. The result of this data can be seen in Fig. 8.
The melting point of NLC has decreased when it is compared with 
melting point of the bulk lipid. This decrease occurs because there is 
a foreign molecule (molecule of the active substance or surfactant) 
which is dissolved in lipid matrix. The melting point and crystallinity 
will change after they are formed in NLC system. The DSC of NLC system 
result shows that enthalpy result (ΔH) is lower than enthalpy (ΔH) bulk 
lipid. Based on DSC result, the melting point of NLC system was bigger 
than the bulk lipid.
The examination of particle morphology in NLC system
The examination result of particle morphology in NLC using scanning 
electron microscopy (SEM) can be seen in Fig. 9.
Based on the observation of particle morphology using SEM with a 
magnification of 10,000 times, each formula showed that the particle 
is almost spherical-shaped in F2 and F3 but very spherical in F1. 
This particle size could produce the controlled release and avoid the 
agglomeration. Particle with a sphere shape has a little contact with 
media which causeslonger diffusion process than non-spherical particle. 
Spherical surface particle has little contact between particlesthat 
causes agglomeration risk between particles is smaller.
Coenzyme Q10 entrapment efficiency
In a number of drugs, the solubility in liquid lipid is greater than in 
solid lipid, and the addition of liquid lipid to solid lipid can damage the 
crystal lattice in the matrix of lipid nanoparticle, then it can increase 
the entrapment efficiency of active ingredient. Entrapment efficiency 
increases by increasing the concentration of liquid lipid. In NLC system, 
high solubility of active ingredient in liquid lipid plays an important role 
in increasing the entrapment efficiency of the active ingredient.
The measurement of entrapment efficiency in the sixth formulas 
of NLC system showed the high result (>70%). The measurement 
result of entrapment efficiency of coenzyme Q10 in NLC system was 
79.19-95.56. The histogram of average % entrapment efficiency of 
some NLC formulas can be seen in Fig. 10
Statistically analysis of particle size using ANOVA showed that there 
was a significant difference between the formulas of NLC system. From 
Fig. 7: The examination result of X-ray diffraction. (a) F3, (b) F2, (c) F1, (d) coenzyme Q10, (e) cetyl palmitate
Fig. 8: The examination result of differential scanning calorimetry, (a) coenzyme Q10; (b) cetyl palmitate; (c) F1; (d) F2; (e) F3
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post-hoc test (Bonferroni), it could be known that there were significant 
differences between the percents of entrapment efficiency in F1 with 
F2 and F3. F1 had the highest percent of entrapment efficiency, and F3 
had the lowest percent of entrapment efficiency. This result is consistent 
with the concentration theory of liquid lipid which can produce the big 
entrapment efficiency because of the active substance solubility in liquid 
lipid increases.
Study of in vivo penetration hasil uji penetrasi coenzyme Q10 NLC 
system in abdominal skin of male Wistar rat using fluorescence 
microscopy
Rhodamine B is used as a fluorescence label has properties that 
solubility to organic solvents and high lipids that can be used as a 
lipophilic dye. Rhodamine B has large conjugated aromatic groups 
that triggered floresensinya properties. Rhodamine B measured at the 
maximum wavelength of 573 nm.
Spherical particle morphology can affect the increase in the surface 
area of particles that contact with skin. Small particle size between 
particles can cause the densed structure, causing occlusifity increased 
due to an increase in particle surface area in contact with the skin. 
Occlusifity led to skin hydration. The hydration of the stratum corneum 
can affect the rate of penetration of the skin [15-17]. The overview of 
in vivo penetration coenzyme Q10 nanostructured lipid carrier in the 
abdominal skin of Wistar rat with fluorescent microscopy can be seen 
in Fig. 11.
CONCLUSION
The coenzyme Q10 NLC system with cetyl palmitate and alpha 
tocopherol acetate as lipid matrixare characterized by small particle size, 
low crystallinity, spherical morphology of particle and high coenzyme 
Q10 entrapment efficiency. Crystal modification led to the formation of 
a more amorphous thereby increasing the drug entrapment [1].
Trapping efficiency can be affected by the merger of the liquid lipid and 
solid lipid. This merger affect the crystal lattice imperfections and leave 
enough space for entry and trapping drug [3].
The addition of liquid lipid in the formula may affect the solubility of the 
drug substance in the system and imperfections of the crystal lattice so 
that when you experience the lipid phase drug compaction many were 
trapped in the system. Increasing the liquid lipid concentration can also 
reduce the viscosity of the NLC system and improve the entrapment 
efficiency. The low viscosity effect on the high rate of release of drug 
substance caused by of constraints (steric barrier) intermolecular 
loose so that the drug molecule is easier to out. Concentration ratio also 
affects the pH, PI, and the zeta potential but the value is not equal with 
the addition of a lipid component [14,18].
Spherical particle morphology can affect the increase in the surface area 
of particles that contact with skin. Small particle size between particles 
can cause the densed structure, causing occlusifity increased due to an 
increase in particle surface area in contact with the skin. Occlusifity led 
to skin hydration. The hydration of the stratum corneum can affect the 
rate of penetration of the skin [8,11].
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